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1. Introduction
  Brucellosis rarely presents with involvement restricted 
to nervous system. Human brucellosis especially 
neurobrucellosis is rarely reported in India, where animals 
are raised in large numbers with low hygiene and hence 
the disease is expectedly endemic. Clinical spectrum of 
neurobrucellosis is varied, several areas of the nervous 
system, both central and peripheral can be involved. 
Identification of the specific neurologic syndromes is 
important as the response to treatment is better in the acute 
form when compared to the chronic form, which is more 
indolent and requires longer duration of therapy. No clear 
cut classification system exist till date for the spectrum of 
clinical syndromes is quite varied. In this rare case report 
of neurobrucellosis, we also discuss regarding the existing 
classification systems and a short review of treatment 
recommendations existing till today. Awareness of the 
conditition and performance of appropriate serological and 
microbiological tests will differentiate neurobrucellosis from 
chronic infections especially tuberculosis.
2. Case report
  A 29 year old shop-keeper with post-polio flaccid 
paralysis of both lower limbs was brought to the emergency 
department with altered sensorium for the past 1 day. 
There was history of intermittent fever since 2 months. 
Fever used to be there for 1-2 days, followed by afebrile 
period for 4-5 days only to recur again. History of loss 
of appetite, night sweats and loss of weight were also 
present. No history of headache, vomiting or joint pain. 
There was history of cattle rearing but no consumption of 
raw milk from cows. On examination he was conscious, 
febrile (100ºF), not verbalizing or obeying commands, 
pulse was 70/min, respiratory rate was 18/min, SpO2 98% 
on room air and BP was 140/80 mmHg. Head was turned 
to right side with clenched teeth and tonically flexed 
upper limbs noted. Pupils were 3 mm symmetrical in 
size but not reacting to light and marked neck stiffness 
was present. Cardiovascular, respiratory and abdomen 
examination were normal. Bystanders claimed this state 
since the last night. The clinical condition was suspected 
to be status epilepticus secondary to meningoencephalitis. 
With intravenous diazepam seizure aborted and he was 
dilantinised.
 Neurobrucellosis is a rare form of localized brucellosis usually with no systemic manifestations. 
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  Full blood count revealed WBC count 15 400/cumm, 80% 
neutrophils.The blood biochemistry, urine routine, chest 
X-ray and ECG were normal.A CT head (Figure 1) showed 
mild hydrocephalus with meningeal enhancement. A 
guarded lumbar puncture was done. CSF analysis showed 
160 WBCs with 99% lymphocytes. CSF-glucose was low (29 
mg/dL), protein was high (157 mg/dL). Cerebrospinal fluid-
adenosine deaminase activity (CSF-ADA) was 21 IU/L. CSF-
PCR for Mycobacterium tuberculosis was negative. Patient 
was started on empirical antitubercular therapy in view 
of 2 months history of fever, meningitis, communicating 
hydrocephalus and lymphocytic predominance of CSF, with 
four drugs [Isoniazid (H), Rifampicin(R), Pyrazinamide (Z) 
and Ethambutol (E)] and dexamethasone and Ceftriaxone. 
Serum was tested for Brucella agglutinins by standard tube 
agglutination test (STAT) and the titer was 320. A week 
later, Brucella species was isolated from CSF by BacT/Alert 
automated blood culture system. 
Figure 1. Computed tomography of brain. 
It shows meningeal enhancement and mild hydrocephalus.
  Following the laboratory confirmation, case was re-
evaluated as neurobrucellosis and HZE stopped and 
dexamethasone continued in view of hydrocephalus and 
tapered. Streptomycin(S) 750 mg/day i.m was started along 
with oral doxycycline 200 mg/day. The dose of rifampicin 
was increased to 600 mg/day and ceftriaxone was continued. 
Fever subsided, disorientation improved and he started 
obeying commands from the second day. Seizures did not 
recur during the recovery period that extended to four weeks. 
Streptomycin was stopped after two weeks and ceftriaxone 
stopped after four weeks and then he was discharged 
symptom free after four weeks. Rifampicin and doxycycline 
were continued. He was reviewed after one month as an 
out-patient and found to be symptom free. He was advised 
to continue rifampicin and doxycycline for 4 more months. 
Lumbar puncture was repeated after 6 months and CSF sent 
for culture was reported as sterile. Hence treatment was 
terminated.
3. Discussion
  Brucellosis is a well known zoonosis endemic in 
Mediterranean, Middle east, Africa Latin America and 
South west Asia. Humans acquire infection commonly 
through consumption of unpastuerised dairy products and 
rarely via cuts and aerosols. Majority of human disease has 
been due to Brucella melitensis. Localized involvement of 
nervous system (neurobrucellosis) has been observed in only 
3-5% of cases in most of the case-series reported world-
wide[1]. Nervous system can be involved in various stages 
of brucellosis i.e. at the onset, during the course of illness, 
convalescence or months after recovery from acute infection. 
The effect on nervous system can be due to direct effect 
of bacilli, cytokines or endotoxins on peripheral nerves, 
spinal cord, meninges and brain. The whole spectrum of 
neurological manifestations include meningitis(M)/meningo-
encephalitis(ME) as the most common manifestations[2] and 
rarely cranial neuropathies, peripheral neuropathies, chorea, 
demyelination, transient ischemic attacks, and psychiatric 
manifestations.
  In 2009, pooled analysis of 187 neurobrucellosis cases with 
35 publications from Turkish medical practice revealed 
varied presentation of neurobrucellosis mimicking various 
pathologies hence a thorough evaluation of patients is 
crucial[3]. Neurobrucellosis presenting as acute psychosis[4], 
thalamic infarction[5], and spastic paraparesis[6] have been 
reported. First case of neurobrucellosis associated with 
hydrocephalus was described by Guney F et al in 2008 after 
consumption of fresh sheep cheese, stressing the need to 
consider neurobrucellosis in any case of hydrocephalus 
especially from endemic areas of brucellosis[7]. In 2006, 
Turkish experience based on  452 cases of spinal brucellosis 
found that the clinical and radiological features are atypical 
and non specific hence difficulty in identifying them, CT/
MRI of spine may be sensitive for diagnosis and follow 
up[8]. Epidemiological, clinical and imaging findings in 
brucellosis with osteoarticular involvement by Poubagher 
et al found that MRI is the method of choice for diagnosing 
osteoarticular and spinal complications of human brucellosis 
and the closest differential diagnosis for tubercular 
spondylodiskitis is brucellosis[9].
  Neurobrucellosis is less commonly reported disease 
in  India although animal brucellosis and seroprevalence 
i n  s p e c i f i c  a r e a s  i s  w e l l  r e p o r t e d .  E x t e n s i v e 
meningoencephalitis, retrobulbar neuritis and pulmonary 
involvement was reported from Lucknow[10]. In 2007, 
hospital based case series of 175 cases of serologically, 
confirmed cases of brucellosis in Bikaner, Northwest India, 
the incidence of neurobrucellosis was 18.86%[11]. Recently 
there are no much reports of cases of neurobrucellosis 
although incidence of brucellosis is on rise. Majority of 
people with cattle rearing profession reside in rural India 
have decreased  access to tertiary care centre and lack of 
awareness among primary care physicians where no specific 
data regarding incidence and prevalence in humans exist, 
though theoretically expected to be endemic. Brucellosis 
closely mimics tuberculosis in its presentation including 
neurobrucellosis. It is confused for tuberculosis.
  Diagnosis of neurobrucellosis rests in neurological 
symptoms  usua l ly  unaccompanied  by  sys temic 
manifestations, positive CSF culture or blood serology and/or 
positive CSF culture, and CT/MRI abnormalities are variable. 
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Al Sous MW et al found three types of imaging abnormalities 
in central nervous system in case of neurobrucellosis-
inflammation, white matter changes and vascular insult. 
The white matter changes may mimic other inflammatory/
infectious disease such as multiple sclerosis, acute 
disseminated encephalomyelitis/Lyme disease[12]. Only one 
case of neurobrucellosis associated with hydrocephalus as a 
radiological feature of neurobrucellosis has been reported[7]. 
Patients with unexplained neurological and psychiatric 
symptoms from endemic areas should raise suspicion of 
neurobrucellosis[13]. For rapid diagnosis of  neurobrucellosis 
light cycler based real time polymerase chain reaction 
based assay in CSF samples is more rapid and sensitive than 
conventional microbiological tests[14].
 Treatment  o f  brucel los is  is  complex requir ing 
protracted administration of more than one antibiotic. 
Recommendations in 2006 suggested that treatment of 
uncomplicated brucellosis in non-pregnant adults should 
be based on a six week regimen of doxycycline combined 
with either streptomycin for two to three weeks or rifampicin 
for six weeks[15]. Systematic review and meta analysis of 
randomized controlled trials in 2008, found that the preferred 
treatment in brucellosis should be with dual/triple regimens 
including an aminoglycoside[16]. Doxycycline and rifampicin 
readily penetrate the blood-brain-barrier (BBB) and 
achieve good CSF concentrations. Concentrations of amino-
glycosides in CSF are therapeutic only when meninges 
are inflamed. In a new case, when the initial presentation 
is M/ME, it is wise to consider other common causes and 
challenge them empirically, until the results of diagnostic 
work-up arrive. Thus ceftriaxone remains an important 
initial drug[1,17]. Ceftriaxone is active against brucella in 
vitro, but results of in vivo studies have not been compelling. 
Given the benefit of doubt, it becomes necessary to include 
ceftriaxone in the initial treatment regimen as it achieves 
good concentration in CSF. 
  Neurobrucellosis generally needs prolonged therapy for 
3-6 months, but no large trials exist. A recent review of most 
case-series on neurobrucellosis have still suggested that 
treatment duration has to be individualized[1], which seems 
reasonable as the spectrum of neurological manifestations 
is diverse. Steroids are warranted in special circumstances 
like our case where there was hydrocephalus. Other 
manifestations requiring steroids include papilledema, 
cranial neuropathies, myeloradiculitis, raised intracranial 
pressure and optic neuropathy[1].
  This case  presented as pyrexia of unknown origin, with 
sudden involvement of central nervous system proved to be 
due to brucellosis can be easily confused with tuberculosis 
with fever, loss of appetite, weight loss, meningeal signs, 
CSF picture and CT feature of hydrocephalus. High index of 
clinical suspicion coupled with appropriate microbiological 
investigations will improve level of case detection. It will 
be reasonable to consider neurobrucellosis as differential 
diagnosis in such circumstances.
  In conclusion, in any case of meningitis or meningoencephalitis 
with lymphocytic predominance in CSF neurobrucellosis is an 
important close differential diagnosis to neurotuberculosis 
in endemic places. Though antitubercular drugs are 
active against Brucella, diagnosis becomes important as 
neurobrucellosis needs prolonged therapy with those specific 
drugs that attain good CSF concentration to exert their 
bactericidal activity. And high index of clinical suspicion 
coupled with appropriate microbiological investigations will 
improve level of case detection.
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